Clinical Trial

Mobile App-Based Infection Monitoring in Familial Mediterranean Fever

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2025 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Familial Mediterranean Fever (FMF) is an autoinflammatory disease characterized by recurrent episodes of fever, abdominal pain, and serositis. FMF attacks often present with fever and systemic symptoms resembling infectious diseases, making it challenging in clinical practice to distinguish between an attack and an infection. Moreover, infections are known to trigger FMF attacks; however, the number of prospective studies evaluating this association remains limited. In the current literature, the frequency of attacks and triggering factors in FMF patients have mostly been assessed through retrospective chart reviews. Such methods are prone to incomplete or recall-based data regarding the onset of attacks and infection-related symptoms. With the growing availability of digital health applications, it has become possible to record disease symptoms in real time and on a regular basis, providing more reliable data for both clinicians and researchers. The present study aims to prospectively evaluate the relationship between infections and disease flares in FMF patients by systematically recording infection symptoms and attack characteristics through a mobile application. This approach is intended to achieve a better understanding of the infection-flare association, improve patient management, and prevent unnecessary treatments. In addition, the feasibility of mobile application-based patient monitoring will be assessed, and its potential contribution to routine clinical practice will be explored.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-30.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-11-25
Trial Details
NCT Number NCT07212764
Lead Sponsor Istanbul University
Conditions Familial Mediterranean Fever (FMF ), Infection, Mobile Application
Enrollment 40 participants
Start Date 2025-11-05
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-03